Abstract
A patient has 30% chance to find an HLA identical sibling donor (SD) and 40% chance to find a suitable unrelated donor (UD), 40% of registered patients on international registries relapse or die before finding a donor. We evaluated the outcome in acute leukemia (AL) patients, whether they had an HLA identical SD, an UD or no donor (ND) after registration on France Greffe de Moelle (FGM) registry, either transplanted later or not. Secondary objectives were to evaluate the impact of intervals diagnosis-allo-HSCT, donor finding-allo-HSCT, registration-allo-HSCT, on OS and EFS.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have